NATCO Pharma Limited (NSE: NATCOPHARM)
India
· Delayed Price · Currency is INR
1,371.50
-17.05 (-1.23%)
Dec 24, 2024, 3:29 PM IST
NATCO Pharma Revenue
NATCO Pharma had revenue of 13.71B INR in the quarter ending September 30, 2024, with 32.94% growth. This brings the company's revenue in the last twelve months to 45.64B, up 28.06% year-over-year. In the fiscal year ending March 31, 2024, NATCO Pharma had annual revenue of 40.02B with 47.76% growth.
Revenue (ttm)
45.64B
Revenue Growth
+28.06%
P/S Ratio
5.38
Revenue / Employee
11.36M
Employees
4,016
Market Cap
245.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 40.02B | 12.94B | 47.76% |
Mar 31, 2023 | 27.09B | 7.62B | 39.17% |
Mar 31, 2022 | 19.46B | -1.10B | -5.35% |
Mar 31, 2021 | 20.56B | 1.41B | 7.37% |
Mar 31, 2020 | 19.15B | -1.80B | -8.57% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNATCO Pharma News
- 13 days ago - Natco Pharma reports 90.8% YoY export growth in November - Business Upturn
- 27 days ago - Natco Pharma shares rise after selling Telangana land for Rs 115.6 crore - Business Upturn
- 4 weeks ago - Natco Pharma sells Telangana land for ₹115.57 crore - Business Upturn
- 4 weeks ago - Natco Pharma submits ANDA for Risdiplam for oral solution - Business Upturn
- 6 weeks ago - Natco Pharma Q2 FY24-25 Results: Revenue rises 32.1% YoY to ₹1,371 crore, profit surges 81.2% to ₹676.5 crore - Business Upturn
- 6 weeks ago - Natco Pharma Q2 FY25 results: Stock surge over 2% ahead of result announcement - Business Upturn
- 6 weeks ago - Q2 results today: Hyundai Motor India, Bosch, Zydus Lifesciences, Nykaa, Unno Minda, 3M India, Natco Pharma, TBO Tek among companies to announce earnings - Business Upturn
- 7 weeks ago - Health groups join patent war over spinal muscular atrophy drug - The Times of India